The global S-Amlodipine market was valued at US$ 36630 million in 2022 and is projected to reach US$ 75160 million by 2029, at a CAGR of 10.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.
S AMLODIPINE belongs to a class of medicines called calcium channel blockers which are primarily taken to treat hypertension (high blood pressure) and angina (chest pain).
This report aims to provide a comprehensive presentation of the global market for S-Amlodipine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding S-Amlodipine. This report contains market size and forecasts of S-Amlodipine in global, including the following market information:
Global S-Amlodipine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global S-Amlodipine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five S-Amlodipine companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the S-Amlodipine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global S-Amlodipine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global S-Amlodipine Market Segment Percentages, by Type, 2022 (%)
Amlodipine Besylate Tablets
Amlodipine Mesylate Tablets
Amlodipine Maleate Tablets
Global S-Amlodipine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global S-Amlodipine Market Segment Percentages, by Application, 2022 (%)
Hypertension
Angina pectoris
Global S-Amlodipine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global S-Amlodipine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies S-Amlodipine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies S-Amlodipine revenues share in global market, 2022 (%)
Key companies S-Amlodipine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies S-Amlodipine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aristo Pharmaceuticals Pvt Ltd
Novartis
Pfizer
Lek
TEVA
Macleods Pharmaceuticals
Caraco Pharmaceutical
Sanis Health
Jamp Pharma
Accel Pharma
Jubilant Generics
Angita Pharma
Florida DOH Central Pharmacy
Chengdu Di'ao Pharmaceutical Group Co., Ltd.
Yangzijiang Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of S-Amlodipine, market overview.
Chapter 2: Global S-Amlodipine market size in revenue and volume.
Chapter 3: Detailed analysis of S-Amlodipine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of S-Amlodipine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global S-Amlodipine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 S-Amlodipine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global S-Amlodipine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global S-Amlodipine Overall Market Size
2.1 Global S-Amlodipine Market Size: 2022 VS 2029
2.2 Global S-Amlodipine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global S-Amlodipine Sales: 2018-2029
3 Company Landscape
3.1 Top S-Amlodipine Players in Global Market
3.2 Top Global S-Amlodipine Companies Ranked by Revenue
3.3 Global S-Amlodipine Revenue by Companies
3.4 Global S-Amlodipine Sales by Companies
3.5 Global S-Amlodipine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 S-Amlodipine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers S-Amlodipine Product Type
3.8 Tier 1, Tier 2 and Tier 3 S-Amlodipine Players in Global Market
3.8.1 List of Global Tier 1 S-Amlodipine Companies
3.8.2 List of Global Tier 2 and Tier 3 S-Amlodipine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global S-Amlodipine Market Size Markets, 2022 & 2029
4.1.2 Amlodipine Besylate Tablets
4.1.3 Amlodipine Mesylate Tablets
4.1.4 Amlodipine Maleate Tablets
4.2 By Type - Global S-Amlodipine Revenue & Forecasts
4.2.1 By Type - Global S-Amlodipine Revenue, 2018-2023
4.2.2 By Type - Global S-Amlodipine Revenue, 2024-2029
4.2.3 By Type - Global S-Amlodipine Revenue Market Share, 2018-2029
4.3 By Type - Global S-Amlodipine Sales & Forecasts
4.3.1 By Type - Global S-Amlodipine Sales, 2018-2023
4.3.2 By Type - Global S-Amlodipine Sales, 2024-2029
4.3.3 By Type - Global S-Amlodipine Sales Market Share, 2018-2029
4.4 By Type - Global S-Amlodipine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global S-Amlodipine Market Size, 2022 & 2029
5.1.2 Hypertension
5.1.3 Angina pectoris
5.2 By Application - Global S-Amlodipine Revenue & Forecasts
5.2.1 By Application - Global S-Amlodipine Revenue, 2018-2023
5.2.2 By Application - Global S-Amlodipine Revenue, 2024-2029
5.2.3 By Application - Global S-Amlodipine Revenue Market Share, 2018-2029
5.3 By Application - Global S-Amlodipine Sales & Forecasts
5.3.1 By Application - Global S-Amlodipine Sales, 2018-2023
5.3.2 By Application - Global S-Amlodipine Sales, 2024-2029
5.3.3 By Application - Global S-Amlodipine Sales Market Share, 2018-2029
5.4 By Application - Global S-Amlodipine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global S-Amlodipine Market Size, 2022 & 2029
6.2 By Region - Global S-Amlodipine Revenue & Forecasts
6.2.1 By Region - Global S-Amlodipine Revenue, 2018-2023
6.2.2 By Region - Global S-Amlodipine Revenue, 2024-2029
6.2.3 By Region - Global S-Amlodipine Revenue Market Share, 2018-2029
6.3 By Region - Global S-Amlodipine Sales & Forecasts
6.3.1 By Region - Global S-Amlodipine Sales, 2018-2023
6.3.2 By Region - Global S-Amlodipine Sales, 2024-2029
6.3.3 By Region - Global S-Amlodipine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America S-Amlodipine Revenue, 2018-2029
6.4.2 By Country - North America S-Amlodipine Sales, 2018-2029
6.4.3 US S-Amlodipine Market Size, 2018-2029
6.4.4 Canada S-Amlodipine Market Size, 2018-2029
6.4.5 Mexico S-Amlodipine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe S-Amlodipine Revenue, 2018-2029
6.5.2 By Country - Europe S-Amlodipine Sales, 2018-2029
6.5.3 Germany S-Amlodipine Market Size, 2018-2029
6.5.4 France S-Amlodipine Market Size, 2018-2029
6.5.5 U.K. S-Amlodipine Market Size, 2018-2029
6.5.6 Italy S-Amlodipine Market Size, 2018-2029
6.5.7 Russia S-Amlodipine Market Size, 2018-2029
6.5.8 Nordic Countries S-Amlodipine Market Size, 2018-2029
6.5.9 Benelux S-Amlodipine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia S-Amlodipine Revenue, 2018-2029
6.6.2 By Region - Asia S-Amlodipine Sales, 2018-2029
6.6.3 China S-Amlodipine Market Size, 2018-2029
6.6.4 Japan S-Amlodipine Market Size, 2018-2029
6.6.5 South Korea S-Amlodipine Market Size, 2018-2029
6.6.6 Southeast Asia S-Amlodipine Market Size, 2018-2029
6.6.7 India S-Amlodipine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America S-Amlodipine Revenue, 2018-2029
6.7.2 By Country - South America S-Amlodipine Sales, 2018-2029
6.7.3 Brazil S-Amlodipine Market Size, 2018-2029
6.7.4 Argentina S-Amlodipine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa S-Amlodipine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa S-Amlodipine Sales, 2018-2029
6.8.3 Turkey S-Amlodipine Market Size, 2018-2029
6.8.4 Israel S-Amlodipine Market Size, 2018-2029
6.8.5 Saudi Arabia S-Amlodipine Market Size, 2018-2029
6.8.6 UAE S-Amlodipine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Aristo Pharmaceuticals Pvt Ltd
7.1.1 Aristo Pharmaceuticals Pvt Ltd Company Summary
7.1.2 Aristo Pharmaceuticals Pvt Ltd Business Overview
7.1.3 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Major Product Offerings
7.1.4 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales and Revenue in Global (2018-2023)
7.1.5 Aristo Pharmaceuticals Pvt Ltd Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis S-Amlodipine Major Product Offerings
7.2.4 Novartis S-Amlodipine Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer S-Amlodipine Major Product Offerings
7.3.4 Pfizer S-Amlodipine Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Lek
7.4.1 Lek Company Summary
7.4.2 Lek Business Overview
7.4.3 Lek S-Amlodipine Major Product Offerings
7.4.4 Lek S-Amlodipine Sales and Revenue in Global (2018-2023)
7.4.5 Lek Key News & Latest Developments
7.5 TEVA
7.5.1 TEVA Company Summary
7.5.2 TEVA Business Overview
7.5.3 TEVA S-Amlodipine Major Product Offerings
7.5.4 TEVA S-Amlodipine Sales and Revenue in Global (2018-2023)
7.5.5 TEVA Key News & Latest Developments
7.6 Macleods Pharmaceuticals
7.6.1 Macleods Pharmaceuticals Company Summary
7.6.2 Macleods Pharmaceuticals Business Overview
7.6.3 Macleods Pharmaceuticals S-Amlodipine Major Product Offerings
7.6.4 Macleods Pharmaceuticals S-Amlodipine Sales and Revenue in Global (2018-2023)
7.6.5 Macleods Pharmaceuticals Key News & Latest Developments
7.7 Caraco Pharmaceutical
7.7.1 Caraco Pharmaceutical Company Summary
7.7.2 Caraco Pharmaceutical Business Overview
7.7.3 Caraco Pharmaceutical S-Amlodipine Major Product Offerings
7.7.4 Caraco Pharmaceutical S-Amlodipine Sales and Revenue in Global (2018-2023)
7.7.5 Caraco Pharmaceutical Key News & Latest Developments
7.8 Sanis Health
7.8.1 Sanis Health Company Summary
7.8.2 Sanis Health Business Overview
7.8.3 Sanis Health S-Amlodipine Major Product Offerings
7.8.4 Sanis Health S-Amlodipine Sales and Revenue in Global (2018-2023)
7.8.5 Sanis Health Key News & Latest Developments
7.9 Jamp Pharma
7.9.1 Jamp Pharma Company Summary
7.9.2 Jamp Pharma Business Overview
7.9.3 Jamp Pharma S-Amlodipine Major Product Offerings
7.9.4 Jamp Pharma S-Amlodipine Sales and Revenue in Global (2018-2023)
7.9.5 Jamp Pharma Key News & Latest Developments
7.10 Accel Pharma
7.10.1 Accel Pharma Company Summary
7.10.2 Accel Pharma Business Overview
7.10.3 Accel Pharma S-Amlodipine Major Product Offerings
7.10.4 Accel Pharma S-Amlodipine Sales and Revenue in Global (2018-2023)
7.10.5 Accel Pharma Key News & Latest Developments
7.11 Jubilant Generics
7.11.1 Jubilant Generics Company Summary
7.11.2 Jubilant Generics S-Amlodipine Business Overview
7.11.3 Jubilant Generics S-Amlodipine Major Product Offerings
7.11.4 Jubilant Generics S-Amlodipine Sales and Revenue in Global (2018-2023)
7.11.5 Jubilant Generics Key News & Latest Developments
7.12 Angita Pharma
7.12.1 Angita Pharma Company Summary
7.12.2 Angita Pharma S-Amlodipine Business Overview
7.12.3 Angita Pharma S-Amlodipine Major Product Offerings
7.12.4 Angita Pharma S-Amlodipine Sales and Revenue in Global (2018-2023)
7.12.5 Angita Pharma Key News & Latest Developments
7.13 Florida DOH Central Pharmacy
7.13.1 Florida DOH Central Pharmacy Company Summary
7.13.2 Florida DOH Central Pharmacy S-Amlodipine Business Overview
7.13.3 Florida DOH Central Pharmacy S-Amlodipine Major Product Offerings
7.13.4 Florida DOH Central Pharmacy S-Amlodipine Sales and Revenue in Global (2018-2023)
7.13.5 Florida DOH Central Pharmacy Key News & Latest Developments
7.14 Chengdu Di'ao Pharmaceutical Group Co., Ltd.
7.14.1 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Company Summary
7.14.2 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Business Overview
7.14.3 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Major Product Offerings
7.14.4 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales and Revenue in Global (2018-2023)
7.14.5 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Key News & Latest Developments
7.15 Yangzijiang Pharmaceutical
7.15.1 Yangzijiang Pharmaceutical Company Summary
7.15.2 Yangzijiang Pharmaceutical Business Overview
7.15.3 Yangzijiang Pharmaceutical S-Amlodipine Major Product Offerings
7.15.4 Yangzijiang Pharmaceutical S-Amlodipine Sales and Revenue in Global (2018-2023)
7.15.5 Yangzijiang Pharmaceutical Key News & Latest Developments
8 Global S-Amlodipine Production Capacity, Analysis
8.1 Global S-Amlodipine Production Capacity, 2018-2029
8.2 S-Amlodipine Production Capacity of Key Manufacturers in Global Market
8.3 Global S-Amlodipine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 S-Amlodipine Supply Chain Analysis
10.1 S-Amlodipine Industry Value Chain
10.2 S-Amlodipine Upstream Market
10.3 S-Amlodipine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 S-Amlodipine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report